UK-Based AstraZeneca Acknowledges Rare Health Risk Of Its Covid Vaccine In Court – News18

UK-based AstraZeneca has acknowledged in court that its Covid vaccine can cause a rare blood clotting condition, British media reports said on Monday.

This follows a class action lawsuit brought by families who allege harm caused by the pharmaceutical giants vaccine. The admission comes amid legal proceedings triggered by claims that the vaccine led to serious health complications, The Daily Mail reported.

In a legal document submitted to a UK court in February, the Cambridge-based company conceded that its vaccine can, in very rare cases, cause TTS," referring to thrombosis with thrombocytopenia syndrome. This condition involves the formation of blood clots accompanied by a low platelet count, which is critical for blood clotting.

Previously known as vaccine-induced immune thrombotic thrombocytopenia (VITT), this exceedingly rare complication has been listed as a potential side effect of the jab. According to the British daily, AstraZenecas admission paves the way for case-by-case settlements concerning individuals affected by the adverse reaction.

In the wake of the lawsuit, AstraZeneca has come out to express sympathy for those affected by adverse reactions to its vaccine while reaffirming its commitment to patient safety. The company underlined regulatory authorities stringent safety standards and reiterated the vaccines overall safety profile.

top videos

Philippines Denies Disputed South China Sea Shoal Deal With China | Beijing Slams US-Manila Drills

France, Germany Sign Deal To Develop Tank Of Future | MGCS To Succeed Leclerc, Leopard By 2040

Houthis Down US MQ-9 Drone | Hezbollah Warns Of Ending Israeli Presence | Hamas Airs Hostage Video

After Niger Setback, US To Withdraw Troops From Chad As Africa Strengthens Ties With Russia, China

Xi Eyes Chinas Victory In Intelligentised Warfare With Biggest Military Restructure In A Decade

Rohit

Rohit is sub-editor at News18.com and covers international news. He previously w

Location: London, United Kingdom (UK)

first published: April 29, 2024, 19:13 IST

See original here:

UK-Based AstraZeneca Acknowledges Rare Health Risk Of Its Covid Vaccine In Court - News18